acalabrutinib,nemolizumab,cyclophosphamide,bortezomib,daratumumab,dexamethasone
takeda,galderma,astrazeneca,janssen
['nemo ', 'borte', 'dexamethasone', 'daratumumab', 'mmsm', ' aca ', 'cyclophosphamide', 'bortezomib']
emn19 study, led by , which evaluates the efficacy of daratumumab combined with bortezomib, cyclophosphamide and dexamethasone in myeloma patients presenting with extramedullary disease will be presented momentarily in #ash2022 #mmsm #medtwitter 
hematolog/hematologist Türk Hematoloji Derne?i Myelom Bilimsel Alt Komite Ba?kan?, Chair of Myeloma Scientific Subcommittee of Turkish Hematology Association